About: Preeclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Preeclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Preeclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study
Creator	Balcells, Joan Carreras, Elena Fernandez-Hidalgo, Nuria Garcia-Manau, Pablo Garcia-Ruiz, Itziar Lopez-Martinez, Maria Maiz, Nerea Mendoza, Manel Rodo, Carlota Rosa, ; Serrano, Berta Suy, Anna
Source	Medline; PMC; WHO
abstract	OBJECTIVES: To investigate the incidence of clinical, ultrasonographic and biochemical findings related to preeclampsia (PE) in pregnancies with COVID‐19, and to assess their accuracy to differentiate between PE and the PE‐like features associated with COVID‐19. DESIGN: A prospective, observational study. SETTING: Tertiary referral hospital. PARTICIPANTS: Singleton pregnancies with COVID‐19 at >20+0 weeks. METHODS: 42 consecutive pregnancies were recruited and classified into two groups: severe and nonsevere COVID‐19, according to the occurrence of severe pneumonia. Uterine artery pulsatility index (UtAPI) and angiogenic factors (soluble fms‐like tyrosine kinase‐1/placental growth factor [sFlt‐1/PlGF]) were assessed in women with suspected PE. MAIN OUTCOME MEASURES: Incidence of signs and symptoms related to PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, abnormal UtAPI and increased sFlt‐1/PlGF. RESULTS: 34 cases were classified as nonsevere and 8 as severe COVID‐19. Six (14.3%) women presented signs and symptoms of PE, all six being among the severe COVID‐19 cases (75.0%). However, abnormal sFlt‐1/PlGF and UtAPI could only be demonstrated in one case. Two cases remained pregnant after recovery from severe pneumonia and had a spontaneous resolution of the PE‐like syndrome. CONCLUSIONS: Pregnant women with severe COVID‐19 can develop a PE‐like syndrome that might be distinguished from actual PE by sFlt‐1/PlGF, LDH and UtAPI assessment. Health care providers should be aware of its existence and monitor pregnancies with suspected preeclampsia with caution.
has issue date	2020-06-01(xsd:dateTime)
bibo:doi	10.1111/1471-0528.16339
bibo:pmid	32479682
has license	no-cc
sha1sum (hex)	9443d6ba68f3e88779c6d555d235e7daa89ec131
schema:url	https://doi.org/10.1111/1471-0528.16339
resource representing a document's title	Preeclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study
has PubMed Central identifier	PMC7300912
has PubMed identifier	32479682
schema:publication	BJOG
resource representing a document's body	covid:9443d6ba68f3e88779c6d555d235e7daa89ec131#body_text
is schema:about of	named entity 'investigate' named entity 'biochemical' named entity 'COVID' named entity 'observational study' named entity 'SARS-CoV-2' named entity 'WHO' named entity 'PlGF' named entity 'placental disease' named entity 'COVID' named entity 'SARS' named entity 'chronic kidney disease' named entity 'elevated liver enzymes' named entity 'R package' named entity 'renin-angiotensin' named entity 'PlGF' named entity '1.1' named entity 'placental insufficiency' named entity 'Misdiagnosis' named entity 'platelet count' named entity 'dry cough' named entity 'pulmonary edema' named entity 'SARS-CoV-2' named entity 'weeks of gestation' named entity 'hypertension' named entity 'severe pneumonia' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'oxidative stress' named entity 'COVID' named entity 'polypharmacy' named entity 'diagnostic criteria' named entity 'hypertension' named entity 'pregnant women' named entity 'antiangiogenic' named entity 'mmHg' named entity 'SARS' named entity 'aspartate aminotransferase' named entity 'endothelial cell' named entity 'biochemical' named entity 'SARS-CoV-2' named entity 'obstetric' named entity 'ICU' named entity 'hypertensive' named entity '1/3' named entity 'pregnancy' named entity 'COVID-19' named entity 'protein' named entity 'proteinuria' named entity 'proteinuria' named entity 'AST' named entity 'signs and symptoms' named entity 'alanine' named entity 'diagnostic criteria' named entity 'infection' named entity 'health care providers' named entity 'fever' named entity 'preeclampsia' named entity 'severe pneumonia' named entity 'liver injury' named entity 'diagnostic criteria' named entity 'PlGF' named entity 'infection' named entity 'high blood pressure' named entity 'creatinine' named entity 'respiratory infection' named entity 'pregnant women' named entity 'SARS-CoV-2' named entity 'proteinuria' named entity 'severe pneumonia' named entity 'LDH' named entity 'Flt-1'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software